Test Price
2,800 AED✅ Home Collection Available
SOX3 Gene Panhypopituitarism, X-Linked Genetic Test – 2,800 AED – Dubai, UAE
Executive Summary & Core Metrics
✅ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited NGS Processing
🚘 Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (Available daily from 8 AM to 11 PM)
📞 Clinical Guidance: Telephonic Post‑Test Clinical Guidance for result interpretation by DHA‑licensed genetic counsellors
💳 Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
The SOX3 gene next‑generation sequencing test detects pathogenic variants causing X‑linked panhypopituitarism, a severe hereditary endocrine disorder. This test provides definitive molecular diagnosis and guides lifelong hormone replacement strategies.
| Feature | Our Test (SOX3 NGS) | Closest Alternative |
|---|---|---|
| Diagnostic Precision | Full gene sequencing with copy number variant detection | Single‑gene Sanger sequencing (misses deep intronic variants) |
| Method | Next‑Generation Sequencing (NGS) with current bioinformatics pipeline | Traditional Sanger sequencing or limited panel |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Interpretation | ACMG‑compliant classification with integrated clinical correlation | Basic variant report without endocrine context |
Physician Insight & Safety Protocols
Advisory: Hormone Therapy Continuation
⚠️ Do not discontinue prescribed hormone replacement therapy or any medication without consulting your doctor. Abrupt cessation may cause life‑threatening adrenal crisis.
Exclusion Criteria & Emergency Red Flags
- Inability to provide written informed consent; individuals under 18 without legal guardian consent.
- Specimen collected outside DHA‑approved conditions or without proper cold‑chain integrity.
- Recent allogeneic blood transfusion or stem cell transplant within 6 months (may cause chimerism artefacts).
- Pregnancy does not exclude testing, but counselling about maternal contamination risk is mandatory.
- Red Flags: If the patient exhibits severe hypoglycaemia, hypotension, or altered consciousness, do not wait for genetic results – seek emergency endocrine care immediately.
Patient FAQ & Clinical Guidance
1. What does the SOX3 NGS test detect?
Snippet: This NGS assay identifies pathogenic sequence variants, deletions, and duplications in the SOX3 gene causing X‑linked panhypopituitarism.
The test reads the entire coding region and flanking splice sites of the SOX3 gene using next‑generation sequencing technology. It can confirm a clinical diagnosis, detect carrier status in females, and inform family planning. Variant interpretation follows current ACMG guidelines, ensuring accurate risk assessment.
2. How long does it take to receive results and are they confidential under UAE law?
Snippet: Results are delivered within 3–4 weeks and protected by Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019.
Your sample is processed in an ISO 9001:2015‑certified laboratory. Genetic data privacy is guaranteed under the UAE Personal Data Protection Law (PDPL) and the Federal Law No. 2 of 2019 concerning health IT. Only you and your referring physician can access the report. A telephonic consultation with a DHA‑licensed genetic counsellor is included to explain the outcome.
3. Is home sample collection available and how should I prepare?
Snippet: Home collection by DHA‑licensed phlebotomists is available 8 AM–11 PM; a pre‑genetic counselling session is mandatory.
You do not need to fast or stop medications. A whole blood sample (1 EDTA tube), extracted DNA, or a single drop of blood on an FTA card is accepted. Before collection, our team schedules a confidential genetic counselling session to draw a detailed pedigree chart of affected family members. This ensures accurate interpretation of the variant in the context of your X‑linked inheritance pattern. WhatsApp +971545488731 to book.
UAE Regulatory & Data Privacy Adherence
This test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and clinical safety are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is stored securely and accessible only to authorised medical professionals.
Clinical & Logistical Metadata
| Test Name | SOX3 Gene Panhypopituitarism, X-Linked Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA tube), extracted DNA, or dried blood spot (FTA card) |
| Methodology Used | Next-Generation Sequencing (NGS) with bioinformatics analysis for SNVs and CNVs |
| ICD-10-CM Code | E23.0 |
| LOINC Code | 81464-6 |
| DHA Facility License & Lab Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians